J. Herrera

Effectiveness and Risk Factors for Virological Outcome of Raltegravir-Based Therapy for Treatment-Experienced HIV-Infected Patients

J. Gaytán-Martínez, J. A. Mata-Marín, Nohemí Núñez-Rodríguez, 2017, Drugs in R&D.

Dyslipidemia and Fasting Glucose Impairment among HIV-InfectedPatients 48-Weeks after the First Antiretroviral Regimen

A.Lara, J. Juan, J. Gaytán-Martínez, 2015 .